Adhesion of sickle neutrophils and erythrocytes to fibronectin

Blood

Volumn 87, Issue 2, 1996, Pages 771-780

  Kasschau, Margaret R ^b   Barabino, Gilda A ^b   Bridges, Kenneth R ^b   Golan, David E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SHEAR STRESS; SICKLE CELL ANEMIA;

EID: 0030033081     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.2.771.bloodjournal872771     Document Type: Article

References (80)

1. Fabry ME, Kaul DK: Sickle cell vaso-occlusion. Hematol Oncol Clin North Am 5:375, 1991
2. Francis RB Jr, Johnson CS: Vascular occlusion in sickle cell disease: Current concepts and unanswered questions. Blood 77:1405, 1991
3. Hebbel RP, Schwartz RS, Mohandas N: The adhesive sickle erythrocyte: Cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clin Haematol 14:141, 1985
4. Nagel RL: Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia. Semin Hematol 28:180, 1991
5. Hebbel RP, Boogaerts MAB, Eaton JW, Steinberg MH: Erythrocyte adherence to endothelium in sickle-cell anemia: A possible determinant of disease severity. N Engl J Med 302:992, 1980
6. Mohandas N, Evans E: Adherence of sickle erythrocytes to vascular endothelial cells: Requirement for both cell membrane changes and plasma factors. Blood 64:282, 1984
7. Wautier JL, Pintigny D, Maclouf J, Wautier MP, Corvazier E, Caen JP: Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J Lab Clin Med 107:210, 1986
8. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
9. Burns ER, Wilkinson WH, Nagel RL: Adherence properties of sickle erythrocytes in dynamic flow systems. J Lab Clin Med 105:673, 1985
10. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, McIntire LV: Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 80:905, 1987
11. Antonucci R, Walker R, Henon J, Orringer E: Enhancement of erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 34:44, 1990
12. Brittain HA, Eckman JR, Wick TM: Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 120:538, 1992
13. Hebbel RP, Moldow CF, Steinberg MH: Modulation of erythrocyte-endothelial interactions and the vaso-occlusive seventy of sickling disorders. Blood 58:947, 1981
14. Mohandas N, Evans E: Sickle erythrocyte adherence to vascular endothelium: Morphologic correlates and the requirement for divalent cations and collagen-binding. J Clin Invest 76:1605, 1985
15. Smith BD, La Celle PL: Erythrocyte-endothelial cell adherence in sickle cell disorders. Blood 68:1050, 1986
16. Wautier JL, Pintigny D, Wautier MP, Paton RC, Galacteros F, Passa P, Caen JP: Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium. J Lab Clin Med 101:911, 1983
17. Kaul DK, Nagel RL, Chen D, Tsai H: Sickle erythrocyte-endothelial interactions in microcirculation: The role of von Willebrand factor and implications for vaso-occlusion. Blood 81:2429, 1993
18. Wick TM, Moake JL, Udden MM, McIntire LV: Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. Am J Hematol 42:284, 1993
19. + sickle reticulocytes to endothelial cells. Blood 80:2634, 1992
20. Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to endothelium: A potential role for platelet activation in sickle cell vaso-occlusion. Blood 80:294, 1992
21. Parise LV, Orringer EP, Joneckis CC: Evidence for a distinct mechanism of sickle cell adhesion by thrombospondin. Blood 82:352, 1993 (abstr, suppl 1)
22. Patel VP, Ciechanover A, Platt O, Lodish HF: Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes. Proc Natl Acad Sci USA 82:440, 1985
23. Yamada KM, Schlesinger DH, Kennedy DW, Pastan I: Characterization of a major fibroblast cell surface glycoprotein. Biochemistry 16:5552, 1977
24. Sekiguchi K, Hakamori S-I: Functional domain structure of fibronectin. Proc Natl Acad Sci USA 77:2661, 1980
25. Stathakis NE, Mosesson MW: Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. J Clin Invest 60:855, 1977
26. Stathakis NE, Mosesson MW, Chen AB, Galanakis DK: Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma. Blood 51:1211, 1978
27. McDonald JA, Kelly DG: Degradation of fibronectin by human leukocyte elastase. J Biol Chem 255:8848, 1980
28. Pierschbacher MD, Ruoslahti E: Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30, 1984
29. Pytela R, Pierschbacher MD, Ruoslahti E: Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40:191, 1985
30. Singer II, Scott S, Kawka DW, Kazazis DM, Gailit J, Ruoslahti E: Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation. J Cell Biol 106:2171, 1988
31. Hynes RO: Fibronectins. New York, NY, Springer-Verlag, 1990
32. Owens MR, Cimino CD: Synthesis of fibronectin by the isolated perfused rat liver. Blood 59:1305, 1982
33. Tamkun JW, Hynes RO: Plasma fibronectin is synthesized and secreted by hepatocytes. J Biol Chem 258:4641, 1983
34. Blatti SP, Foster DN, Ranganathan G, Moses HL, Getz MJ: Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci USA 85:1119, 1988
35. Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH: Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 79:1285, 1987
36. Thompson KL, Assoian R, Rosner MR: Transforming growth factor-beta increases transcription of the genes encoding the epidermal growth factor receptor and fibronectin in normal rat kidney fibroblasts. J Biol Chem 263:19519, 1988
37. Cofano F, Comoglio PM, Landolfo S, Tarone G: Mouse immune interferon enhances fibronectin production of elicited macrophages. J Immunol 133:3102, 1984
38. Czaja MJ, Weiner FR, Eghbali M, Gimbrone MA, Eghbali M, Zern MA: Differential effects of gamma-interferon on collagen and fibronectin gene expression J Biol Chem 262:13348, 1987
39. Dyck RF, Rogers SL: Fibronectin is an acute phase reactant in mice. Clin Invest Med 8:148, 1985
40. Pick-Kober K-H, Munker D, Gressner AM. Fibronectin is synthesized as an acute phase reactant in rat hepatocytes J Clin Chem Clin Biochem 24:521, 1986
41. Oliver N, Newby RF, Furcht LT, Bourgeois S: Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts. Cell 33:287, 1983
42. Amrani DL, Mauzy-Melitz D, Mosesson MW: Effect of hepatocyte-stimulating factor and glucocorticoids on plasma fibronectin levels Biochem J 238:365, 1986
43. Nimmer D, Bergtrom G, Hirano H, Amrani DL: Regulation of plasma fibronectin biosynthesis by glucocorticoids in chick hepatocyte cultures. J Biol Chem 262:10369, 1987
44. Lanser ME, Brown GE: Stimulation of rat hepatocyte fibronectin production by monocyte-conditioned medium is due to interleukin-6. J Exp Med 170:1781, 1989
45. Hagiwara T, Suzuki H, Kono I, Kashiwagi H, Akiyama Y, Onozaki K: Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes. Am J Pathol 136:39, 1990
46. Natsuka S, Isshiki H, Akira S, Kishimoto T: Augmentation of haptoglobin production in Hep3B cell line by a nuclear factor NF-IL6. FEBS Lett 291:58, 1991
47. Diggs LW: The blood picture in sickle cell anemia. South Med J 25:615, 1932
48. Boggs DR, Hyde F, Srodes C: An unusual pattern of neutrophil kinetics in sickle cell anemia. Blood 41:59, 1973
49. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 330:1639, 1994
50. Mansour MA: A severity profile of possible determinants of mortality in adult sickle cell anemia (doctorate dissertation). Chicago, IL, University of Illinois, 1986
51. Griffin TC, McIntire D, Buchanan GR: High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 330:733, 1994
52. Chien S: Viscoelastic properties of leukocytes, in Meiselman HJ, Lichtman MA, LaCelle PL (eds): White Cell Mechanics, Basic Science and Clinical Aspects. New York, NY, Liss, 1984, p 19
53. Lipowsky HH, Chien S: Role of leukocyte-endothelium adhesion in affecting recovery from ischemic episodes. Ann NY Acad Sci 565:308, 1989
54. Diepenhorst P, Sprokholt R, Prins HK: Removal of leukocytes from whole blood and erythrocyte suspensions by filtration through cotton wool. Vox Sang 23:308, 1972
55. Aplin A: Model matrices for studying cell adhesion, in Curtis ASG, Lackie JM (eds): Measuring Cell Adhesion. New York, NY, Wiley, 1991, p 77
56. Nagel RL, Fabry ME, Billett HH, Kaul DK: Sickle cell painful crisis: A multifactorial event. Prog Clin Biol Res 240:361, 1987
57. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Rheological studies of erythrocyte-endothelial cell interactions in sickle cell disease, in Nagel R (ed): Pathophysiological Aspects of Sickle Cell Vaso-Occlusion. New York, NY, Liss, 1987, p 113
58. Kaul DK, Fabry ME, Nagel RL: Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 86:3356, 1989
59. Kaul DK, Chen D, Zhan J: Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells. Blood 83:3006, 1994
60. Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM: Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest 80:1503, 1987
61. Sowemimo-Coker S, Haywood LJ, Meiselman HJ, Francis RB: Interleukin-1 increases adherence of normal and sickle erythrocytes to endothelial cells. Blood 74:313, 1989
62. Clark MR, Mohandas N, Shohet SB. Deformability of oxygenated irreversibly sickled cells. J Clin Invest 65:189, 1980
63. Boghossian SH, Nash G, Dormandy J, Bevan DH: Abnormal neutrophil adhesion in sickle cell anemia and crisis: Relationship to blood rheology. Br J Haematol 78.437, 1991
64. Dinarello CA: Interleukin-1. Adv Pharmacol 25:21, 1994
65. Tracey KJ, Cerami A: Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491, 1994
66. Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 54:1, 1993
67. van Snick J: Interleukin-6: An overview. Annu Rev Immunol 8:253, 1990
68. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 55:97, 1994
69. Sheron N, Bird G, Goka J, Alexander G, Williams R: Elevated plasma interleukin-6 and increased seventy and mortality in alcoholic hepatitis. Clin Exp Immunol 84:449, 1991
70. Hirano T, Kishimoto T: Interleukin-6, in Sporn M, Roberts A (eds): Peptide Growth Factors and Their Receptors. Berlin, Germany, Springer-Verlag, 1990, p 633
71. Jablons DM, McIntosh JK, Mule JJ, Nordan RP, Rudikoff S, Lotze MT: Induction of interferon-beta 2/interleukin-6 by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state. Ann NY Acad Sci 557:157, 1989
72. Calandra T, Gerain J, Heumann D, Baumgartner J-D, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23, 1991
73. Yoshimoto T, Nakanishi K, Hirose S, Hiroishi K, Okamura H, Takemoto Y, Kanamaru A, Hada T, Tamura T, Kakishita E, Higashino K: High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J Immunol 148:3596, 1992
74. Akira S, Hirano T, Taga T, Kishimoto T: Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 4:2860, 1990
75. Henschler R, Lindemann A, Brach MA, Machensen A, Mertelsmann RH, Herrmann F: Expression of functional receptors for interleukin-6 by human polymorphonuclear leukocytes. FEBS Lett 283:47, 1991
76. Borish L, Rosenbaum R, Albury L, Clark S: Activation of neutrophils by recombinant interleukin-6. Cell Immunol 121:280, 1989
77. Kharazmi A, Nielsen H, Rechnitzer C, Bendtzen K: Interleukin-6 primes human neutropil and monocyte oxidative burst response. Immunol Lett 21:177, 1989
78. Pommier CG, O'Shea J, Chused T, Yancey K, Frank MM, Takahashi T, Brown EJ: Studies on the fibronectin receptors of human peripheral blood leukocytes: Morphologic and functional characterization. J Exp Med 159:137, 1984
79. Brown EJ, Goodwin JL: Fibronectin receptors of phagocytes. Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes. J Exp Med 167:777, 1988
80. Singer II, Scott S, Kawka DW, Kazazis DM: Adhesomes: Specific granules containing receptors for laminin C3bi/fibrinogen. fibronectin, and vitronectin in human polymorphonuclear leukocytes and monocytes. J Cell Biol 109:3169, 1989